Cloricromen

Synonyms: Cloricromene; AD6
Cloricromen (Cloricromene) 是一种具有口服活性的血小板抑制剂,可抑制血栓烷 B2 (thromboxane B2) 释放、β-血栓球蛋白 (β-thromboglobulin) 生成及血栓形成,并抑制 LPS (MS-X54539) 诱导的 NF-κB 活化、氧化活性及 TNF-α 表达,在休克和外周缺血动物模型中表现出保护活性,可用于心肌缺血/再灌注损伤及缺血性脑血管病的相关研究。
产品编号: MS-X94899 CAS No.: 68206-94-0 分子式: C20H26ClNO5 分子量: 395.88
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

Cloricromen (Cloricromene) 是一种具有口服活性的血小板抑制剂,可抑制血栓烷 B2 (thromboxane B2) 释放、β-血栓球蛋白 (β-thromboglobulin) 生成及血栓形成,并抑制 LPS (MS-X54539) 诱导的 NF-κB 活化、氧化活性及 TNF-α 表达,在休克和外周缺血动物模型中表现出保护活性,可用于心肌缺血/再灌注损伤及缺血性脑血管病的相关研究。

生物实验数据

生物活性 Cloricromen (Cloricromene) is an orally active platelet inhibitor that inhibits thromboxane B2 release, β-thromboglobulin production, and thrombosis, suppresses LPS (MS-X54539)-induced NF-κB activation, oxidative activity, and TNF-α expression, exhibits protective activity in animal models of shock and peripheral ischemia, and can be used in research related to myocardial ischemia/reperfusion injury and ischemic cerebrovascular disease.
体外研究
(In Vitro)

Cloricromen (1-50 μM; 10 min pre-incubation before 24 h LPS exposure) 可强效抑制脂多糖诱导大鼠肺泡巨噬细胞释放 TNF-α,其 IC50 为 5.9 μM;且不会引发细胞毒性。
Cloricromen (10 μM; 10 min pre-incubation before 2 h LPS exposure) 可在大鼠肺泡巨噬细胞中抑制脂多糖诱导的 TNF-α mRNA 表达,提示其作用机制为转录前调控。
Cloricromen (1-50 μM; 10 min pre-incubation before 15 min LPS exposure) 可通过靶向激活过程而非直接结合 DNA,以剂量依赖性方式抑制脂多糖诱导的大鼠肺泡巨噬细胞中 NF-κB 激活。
Cloricromen (10 μM; 10 min pre-incubation before 5 min LPS exposure) 对脂多糖诱导的大鼠肺泡巨噬细胞中 PKC-βII 转位仅具有轻微作用。
Cloricromen (hydrochloride) (10 μM; 10 min pre-incubation before LPS exposure) 可显著抑制脂多糖诱导的大鼠肺泡巨噬细胞氧化活性。

RT-PCR

Cell Line: rat alveolar macrophages
Concentration: 10 μM
Incubation Time: 10 min pre-incubation before 2 h LPS exposure
Result: Inhibited LPS-induced TNF-α mRNA expression by ~60%.
体内研究
(In Vivo)

Cloricromen (30-300 μg/kg/min;静脉注射;持续输注;从缺血前 15 分钟至再灌注 2 小时) 可在心肌缺血再灌注损伤的兔中诱导剂量依赖性的心脏保护作用。
Cloricromene 通过抑制 TNF-α 产生、提高存活率并逆转相关血流动力学和血液学异常,对脂多糖诱导的雄性 Sprague-Dawley 大鼠内毒素休克起到保护作用。
Cloricromene 可减小遭受缺血再灌注损伤的雄性 Sprague-Dawley 大鼠的心肌梗死面积。
Cloricromene (0.25-0.50 mg/kg;静脉注射;持续输注;最长 70 分钟) 可减轻家兔心肌缺血再灌注损伤。

Animal Model: New Zealand white rabbits (male, 2-3 kg, myocardial ischaemia-reperfusion model via 1 hour left coronary artery occlusion followed by 2 hours reperfusion)
Dosage: 30; 300 μg/kg/min
Administration: i.v.; continuous infusion; from 15 minutes pre-occlusion through 2-hour reperfusion
Result: Reduced infarct size to 40.8% of the area at risk.
Significantly reduced myeloperoxidase activity in infarcted myocardial tissue.
Showed no attenuation of occlusion-induced ST-segment elevation.
Detected no inhibition of ex vivo platelet aggregation induced by ADP or collagen.
Caused no significant changes in mean arterial blood pressure, pressure-rate index, left ventricular systolic pressure, or heart rate relative to controls.
Significantly reduced myeloperoxidase activity in infarcted myocardial tissue.
Significantly reduced occlusion-induced ST-segment elevation to 0.08 mV at 20 minutes post-occlusion and returned to basal levels by 1 hour post-occlusion.
Inhibited ex vivo platelet aggregation, with collagen-induced aggregation reduced to 57% at end of occlusion and 13% after 2-hour reperfusion, and ADP-induced aggregation reduced to 74% at end of occlusion and 53% after 2-hour reperfusion.
Caused a slight, non-significant decrease in mean arterial blood pressure, a significant decrease in left ventricular systolic pressure at end of occlusion, and a significant increase in heart rate at end of reperfusion, with no change in pressure-rate index.
Animal Model: New Zealand white rabbits (pathogen-free, 2.5-3.5 kg)
Dosage: 3.6 μg/kg/min; 7.1 μg/kg/min (for transient ST elevations); total 0.25-0.50 mg/kg
Administration: i.v.; continuous infusion; up to 70 minutes
Result: Reversed transient ST-segment elevations in 3 out of 4 affected rabbits.
Showed no significant difference in chemiluminescence between anterior and posterior ventricular walls.
Achieved an anterior/posterior wall chemiluminescence ratio of 0.95.
Resulted in an overall myocardial-cell injury score of 1.4.
Preserved myocyte subcellular architecture with only mild or moderate mitochondrial edema.
Maintained well-preserved capillary structure with occasional mild/moderate endothelial luminal protrusions.
Observed focal subendocardial necrosis in 3 out of 10 treated rabbits.
Prevented reperfusion arrhythmias.

化学信息

分子量 395.88
分子式 C20H26ClNO5
CAS No. 68206-94-0
别名 Cloricromene; AD6

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础